|
For Immediate Release |
Contact: Jay Zager |
|
June 23, 2005 |
(860) 644-1551 |
|
SOUTH WINDSOR, CT -- Gerber Scientific, Inc. (NYSE: GRB) today reported a loss for the three months ended April 30, 2005 of $4.8 million, or $0.21 per diluted share, on revenue of $133.4 million compared with earnings of $3.6 million, or $0.16 per diluted share, on revenue of $136.7 million for the three months ended April 30, 2004.For the fiscal year ended April 30, 2005, the Company reported a loss of $5.6 million, or $0.25 per diluted share, on revenue of $517.3 million compared with earnings of $5.5 million, or $0.25 per diluted share, on revenue of $516.8 million for the year ended April 30, 2004. Included in the operating results for the three and twelve months ended April 30, 2005 were pre-tax charges amounting to $5.6 million ($0.16 per diluted share) and $10.5 million ($0.31 per diluted share), respectively, representing inventory write-downs associated with Gerber Coburn and Spandex business re-engineering initiatives, product discontinuation costs, and other adjustments. Also included in the operating results for the three and twelve months ended April 30, 2005 were external Sarbanes-Oxley compliance costs of $2.3 million ($.07 per diluted share) and $3.4 million ($0.10 per diluted share), respectively. Included in the operating results for the three and twelve month periods ended April 30, 2004 were pre-tax charges amounting to $0.9 million ($0.03 per diluted share) and $1.4 million ($0.04 per diluted share), respectively, representing inventory write-downs associated with business re-engineering initiatives. Foreign currency translation had the effect of increasing revenue by approximately $5.1 million and $20.3 million in the fiscal 2005 fourth quarter and full year, respectively, over the fiscal 2004 comparable periods. Gerber Scientific president and chief executive officer, Marc T. Giles, said: "The fundamental drivers of our business were in line with our expectations for the fourth quarter. Orders, revenue, and backlog were the highest for the fiscal year. New product introductions, including the GERBER EDGE FX and GERBER SOLARA in the Sign Making and Specialty Graphics segment and the DTL Generator in the Ophthalmic Lens Processing segment, contributed to the increases. During the fourth quarter, our operating results were adversely affected by significant costs primarily associated with Sarbanes-Oxley compliance, a product discontinuation in the Sign Making and Specialty Graphics segment, and inventory write-downs related to Gerber Coburn and Spandex business re-engineering. While elements of our turnaround strategy resulted in substantial charges in fiscal 2005, we finished the consolidation of our manufacturing operations and the implementation of SAP throughout most of the Company in the year. We anticipate that these achievements and further business process improvements will result in operating leverage as traction for our new products develops." The Company had total debt of $45.7 million at April 30, 2005 compared with total debt of $45.2 million at January 31, 2005. Within this overall debt level, the Company reduced its higher cost term debt by almost half, from $18.5 million at January 31, 2005 to $10.3 million at April 30, 2005. Based on the fourth quarter operating results and a scheduled tightening of financial covenant compliance requirements under the Company's revolving credit and term loan agreements, the Company was not in compliance with certain financial covenants in those agreements at April 30, 2005. On June 21, 2005, the lenders under the revolving credit and term loan agreements waived compliance with those covenants at April 30, 2005. The Company is currently in discussions with its lenders to amend its credit agreements going forward, which it expects to complete in the near term. The Company believes that borrowings under its revolving credit facility, operating cash flows, and cash on hand will be sufficient to support its near term working capital and other cash requirements. For additional information, including segment and order entry information, please see our annual report on Form 10-K for the year ended April 30, 2005, to be filed with the Securities and Exchange Commission. About Gerber Scientific, Inc. Forward-looking Statements: |
|
|
GERBER SCIENTIFIC, INC. AND SUBSIDIARIES (Unaudited) |
||||||
|
|
Three Months Ended |
Years Ended |
||||
|
In thousands (except per share amounts) |
2005 |
2004(1) |
2005 |
2004(1) |
||
|
Revenue: |
||||||
|
Product sales |
$ 118,283 |
$ 121,481 |
$ 458,055 |
$ 460,466 |
||
|
Service sales |
15,149 |
15,203 |
59,267 |
56,350 |
||
|
133,432 |
136,684 |
517,322 |
516,816 |
|||
|
Costs and Expenses: |
||||||
|
Cost of products sold |
87,349 |
84,736 |
323,392 |
319,468 |
||
|
Cost of services sold |
10,602 |
10,335 |
39,236 |
35,255 |
||
|
Selling, general and administrative |
34,875 |
28,381 |
127,249 |
115,910 |
||
|
Research and development |
6,307 |
6,560 |
25,037 |
25,207 |
||
|
Restructuring charges |
437 |
--- |
3,031 |
2,482 |
||
|
139,570 |
130,012 |
517,945 |
498,322 |
|||
|
Operating (loss) income |
(6,138) |
6,672 |
(623) |
18,494 |
||
|
Other income (expense), net |
16 |
(698) |
(2,584) |
(4,206) |
||
|
Interest expense |
(1,421) |
(2,757) |
(6,747) |
(12,085) |
||
|
(Loss) earnings before income taxes |
(7,543) |
3,217 |
(9,954) |
2,203 |
||
|
(Benefit) for income taxes |
(2,754) |
(337) |
(4,393) |
(3,331) |
||
|
Net (loss) earnings |
$ (4,789) |
$ 3,554 |
$ (5,561) |
$ 5,534 |
||
|
======= |
======= |
======= |
======= |
|||
|
(Loss) earnings per share of common stock: |
||||||
|
Basic |
$ (.21) |
$ .16 |
$ (.25) |
$ .25 |
||
|
Diluted |
(.21) |
.16 |
(.25) |
.25 |
||
|
Average shares outstanding: |
||||||
|
Basic |
22,278 |
22,216 |
22,261 |
22,197 |
||
|
Diluted |
22,278 |
22,440 |
22,261 |
22,393 |
||
(1) Certain reclassifications have been made to the prior year amounts to conform to the fiscal 2005 presentation.
GERBER SCIENTIFIC, INC. AND SUBSIDIARIES (Unaudited) |
|||
|
|
April 30, 2005 |
April 30, 2004 |
|
| Assets: |
|||
| Current Assets: |
|||
|
Cash and cash equivalents |
$ 6,148 |
$ 6,371 |
|
Accounts receivable, net |
89,800 |
90,453 |
|
|
Inventories |
52,363 |
49,696 |
|
|
Prepaid expenses and other current assets |
13,851 |
11,307 |
|
|
162,162 |
157,827 |
||
| Property, Plant and Equipment, Net |
39,923 |
42,574 |
|
| Intangible Assets, Net |
59,399 |
59,010 |
|
| Deferred Income Taxes |
29,788 |
19,738 |
|
| Other Assets |
6,014 |
7,737 |
|
|
$ 297,286 |
$ 286,886 |
||
|
======= |
======= |
||
| Liabilities and Shareholders' Equity: |
|||
| Current Liabilities: |
|||
|
Current maturities of long-term debt |
$ 29,482 |
$ 12,509 |
|
|
Accounts payable |
47,023 |
43,397 |
|
|
Accrued and other liabilities |
57,052 |
46,135 |
|
|
133,557 |
102,041 |
||
| Noncurrent Liabilities: |
|||
|
Long-term debt |
16,260 |
46,512 |
|
|
Other long-term liabilities |
31,663 |
20,731 |
|
|
47,923 |
67,243 |
||
| Shareholders' Equity |
115,806 |
117,602 |
|
|
$ 297,286 |
$ 286,886 |
||
|
======= |
======= |
||